Guilty: stem cell researcher

A former member of a high profile stem cell biology research team at the University of Minnesota has been found guilty of falsifying data, a university investigatory panel has ruled. Morayma Reyes, a former PhD student in the lab of prominent stem cell biologist linkurl:Catherine Verfaillie,;http://www.kuleuven.be/cv/u0048658e.htm was under investigation by the university for fabricating data in a linkurl:2002 Nature paper;http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&db=pubmed&cmd=Se

Written byAndrea Gawrylewski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
A former member of a high profile stem cell biology research team at the University of Minnesota has been found guilty of falsifying data, a university investigatory panel has ruled. Morayma Reyes, a former PhD student in the lab of prominent stem cell biologist linkurl:Catherine Verfaillie,;http://www.kuleuven.be/cv/u0048658e.htm was under investigation by the university for fabricating data in a linkurl:2002 Nature paper;http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&db=pubmed&cmd=Search&term=%22Nature%22[Jour]%20AND%202002[pdat]%20AND%20Reyes%20M[author] which identified a certain type of bone marrow stem cell capable of giving rise to every type of cell in the body. It was the first time that adult stem cells had been shown to be pluripotent -- only embryonic stem cells had displayed that capability before. After the results were published, other researchers had trouble replicating the findings. Early in 2007, a New Scientist reporter noticed that some data resembled data in a patent claim, data in another paper in the journal Experimental Hematology from 2001, and data in an article in the journal Blood. The magazine linkurl:raised the issue;http://www.the-scientist.com/news/display/52892/ with Nature and the university. An investigation last year conducted by the university found that the duplication in Experimental Hematology was not a result of misconduct. In June of last year, linkurl:Nature retracted the figures;http://www.the-scientist.com/news/display/53279/ in question from the paper, stating that they did not affect the overall findings of the paper. The current report issued by the University of Minnesota panel states that Reyes is guilty of falsifying the data in Blood, and calls for the article's retraction. It also found the same data in a fourth article in the Journal of Clinical Investigation, although did not rule that a case of misconduct. The panel cleared Verfaillie and the other authors on the papers of fraud. "I have initiated a number of additional oversight measures designed to further enhance the integrity of research and scientific publications coming from my lab," Verfaillie, now at Catholic University of Leuven in Belgium linkurl:told New Scientist.;http://www.newscientist.com/channel/being-human/dn14886-stemcell-researcher-guilty-of-falsifying-data.html?feedId=online-news_rss20 "I am confident that these measures will avoid the recurrence of a similar problem in the future." No action has been set against Reyes, who is now an assistant professor at the University of Washington, Seattle.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies